Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Aiham Qdaisat Image

      Aiham Qdaisat, MD, MS, MPH

      Department of Emergency Medicine, Division of Internal Medicine

      Present Title & Affiliation

      Primary Appointment

      Assistant Professor, Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Dual/Joint/Adjunct Appointment

      Assistant Professor, Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Degree-Granting Education

      2024The University of Texas Health Science Center at Houston - UTHealth Houston - School of Public Health, Houston, Texas, US, Epidemiology/Public health informatics, Master of Public Health
      2010Jordan University of Science and Technology, Irbid, JO, Medicine, Doctor of Medicine
      2024The University of Texas Health Science Center at Houston - UTHealth Houston, Houston, Texas, US, Biomedical Informatics, Master of Science in Biomedical Informatics

      Postgraduate Training

      2020-2021Graduate Certificates, Biomedical Informatics, UTHealth School of Biomedical Informatics (SBMI), Houston, Texas

      Experience & Service

      Faculty Academic Appointments

      Instructor, Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2024

      Other Professional Positions

      Visiting Scientist, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2019

      Intramural Institutional Committee Activities

      Member, DoIM research and education subcommittee, The University of Texas MD Anderson Cancer Center, 2023 - Present

      Member, DoIM Research Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present

      Extramural Institutional Committee Activities

      Chair, Data and research design standardization workgroup, Comprehensive Oncologic Emergencies Research Network (CONCERN), 2022 - Present

      Editorial Activities

      Review editor, Frontiers in Cardiovascular Medicine - Thrombosis and Haemostasis section, 2023 - Present

      Special issue editor - "Oncologic Emergencies: The Emergency Care of Cancer Patients", Cancers, 2023 - Present

      Honors & Awards

      2023Best poster in 2023 Oncologic emergency medicine conference, MD Anderson Cancer Center
      2023SBMI Dean’s Excellence Scholarship, UTHealth school of biomedical informatics
      2021Top Cited Article 2020-2021 in the Journal of the American College of Emergency Physicians Open, Wiley Publisher
      2019Division of internal medicine- clinical research distinguished paper award (2019), MD Anderson Cancer Center
      2018First place oncologic emergency medicine poster presentation, MD Anderson Cancer Center
      2017Outstanding performance award, MD Anderson Cancer Center
      2016Awesome Job Award, MD Anderson Cancer Center

      Professional Memberships

      Comprehensive Oncologic Emergencies Research Network

      2021 - Present

      Healthcare Information and Management Systems Society

      2020 - Present

      American Association for Cancer Research

      2018 - Present

      Society of Hematologic Oncology

      2018 - Present

      American Society of Clinical Oncology

      2018 - Present

      Grant & Contract Support

      Date: 2022 - 2024
      Title:Neural network prediction of appropriate disposition from the Acute Cancer Care Center of cancer patients needing emergency treatment
      Funding Source:MD Anderson - DoIM Research & Quality Improvement Award
      Role:Co-I

      Selected Publications

      Peer-Reviewed Articles

      1. Yilmaz S, Aryal K, King J, Bischof JJ, Hong AS, Wood N, Gould Rothberg BE, Hudson MF, Heinert SW, Wattana MK, Coyne CJ, Reyes-Gibby C, Todd K, Lyman G, Klotz A, Abar B, Grudzen C, Bastani A, Baugh CW, Henning DJ, Bernstein S, Rico JF, Ryan RJ, Yeung SJ, Qdaisat A, Padela A, Madsen TE, Liu R, Adler D. Understanding oncologic emergencies and related emergency department visits and hospitalizations: a systematic review. BMC Emerg Med 25(1):40, 2025. e-Pub 2025. PMID: 40045233.
      2. Wattana, M, Davenport, M, Bischof, JJ, Lindsay, A, Pettit, NR, Menendez, JR, Harper, K, Lipe, D, Qdaisat, AZ. Perceived Gaps in Oncologic Emergency Care for Patients with Cancer. Cancers 17(5), 2025. e-Pub 2025. PMID: 40075677.
      3. Burk, KJ, Stroh, JJ, Larkin, K, Chaftari, P, Langabeer, DM, Menendez, JR, Woodruff, JF, Hargrave, J, Zhu, H, Long, JP, Yeung, SJ, Alagappan, K, Qdaisat, AZ. Empathy Unmasked. Journal of Emergency Medicine 68:43-53, 2025. e-Pub 2025. PMID: 39800593.
      4. Burk KJ, Stroh JJ, Larkin K, Chaftari P, Langabeer DM, Menendez JR, Woodruff JF, Hargrave J, Zhu H, Long JP, Yeung SJ, Alagappan K, Qdaisat A. Empathy Unmasked: Patient Perception of Physician Empathy in an Oncologic Emergency Setting. A Randomized Controlled Trial Comparing Personal Protective Equipment Wear versus Unmasked Video Communication. J Emerg Med 68:43-53, 2025. e-Pub 2025. PMID: 39800593.
      5. Qdaisat, AZ, Stroh, E, Reyes-Gibby, CC, Wattana, M, Viets-Upchurch, J, Li, Z, Page, VD, Fatima, H, Chaftari, P, Elsayem, A. Severity of Symptoms as an Independent Predictor of Poor Outcomes in Patients with Advanced Cancer Presenting to the Emergency Department. Cancers 16(23), 2024. e-Pub 2024. PMID: 39682175.
      6. Qdaisat A, Stroh E, Reyes-Gibby C, Wattana MK, Viets-Upchurch J, Li Z, Page VD, Fatima H, Chaftari P, Elsayem A. Severity of Symptoms as an Independent Predictor of Poor Outcomes in Patients with Advanced Cancer Presenting to the Emergency Department: Secondary Analysis of a Prospective Randomized Study. Cancers (Basel) 16(23), 2024. e-Pub 2024. PMID: 39682175.
      7. Wechsler AH, Sandoval M, Viets-Upchurch J, Cruz Carreras M, Page VD, Elsayem A, Qdaisat A, Yeung SJ. Prior Advanced Care Planning and Outcomes of Cardiopulmonary Resuscitation in the Emergency Department of a Comprehensive Cancer Center. Cancers (Basel) 16(16), 2024. e-Pub 2024. PMID: 39199606.
      8. Byun JY, Aiyeolemi A, Qdaisat A, Park C. Association between epidermal growth factor receptor-tyrosine kinase inhibitors and venous thromboembolism among older patients with advanced non-small cell lung cancer. Cancer, 2024. e-Pub 2024. PMID: 38848305.
      9. Yeung SJ, Qdaisat A, Bischof JJ, Caterino JM, Kyriacou DN, Coyne Md C. A case series of adrenal insufficiency (likely due to hypophysitis) in cancer patients treated with immune checkpoint inhibitors. Am J Emerg Med 80:227.e1-227.e5, 2024. e-Pub 2024. PMID: 38705758.
      10. Wattana MK, Lindsay A, Davenport M, Pettit NR, Menendez JR, Li Z, Lipe DN, Qdaisat A, Bischof JJ. Current gaps in emergency medicine core content education for oncologic emergencies: A targeted needs assessment. AEM Educ Train 8(3):e10987, 2024. e-Pub 2024. PMID: 38765712.
      11. He X, Ji J, Qdaisat A, Esteva FJ, Yeung SJ. Long-term overall survival of patients who undergo breast-conserving therapy or mastectomy for early operable HER2-Positive breast cancer after preoperative systemic therapy: an observational cohort study. Lancet Reg Health Am 32:100712, 2024. e-Pub 2024. PMID: 38495316.
      12. Reyes-Gibby CC, Qdaisat A, Ferrarotto R, Fadol A, Bischof JJ, Coyne CJ, Lipe DN, Hanna EY, Shete S, Abe JI, Yeung SJ. Cardiovascular events after cancer immunotherapy as oncologic emergencies: Analyses of 610 head and neck cancer patients treated with immune checkpoint inhibitors. Head Neck 46(3):627-635, 2024. e-Pub 2024. PMID: 38151809.
      13. Reyes-Gibby CC, Caterino JM, Coyne CJ, Kyriacou DN, Qdaisat A, McQuade J, Owen DH, Bischof JJ, Shete S, Yeung SJ. Immune-related adverse event in the emergency department: methodology of the immune-related emergency disposition index (IrEDi). Emerg Cancer Care 3(1), 2024. e-Pub 2024. PMID: 38725994.
      14. Byun JY, Han S, Qdaisat A, Park C. Long QT syndrome after using EGFR-TKIs in older patients with advanced non-small cell lung cancer. Expert Opin Drug Saf:1-9, 2023. e-Pub 2023. PMID: 38088244.
      15. Dragomir MP, Fuentes-Mattei E, Winkle M, Okubo K, Bayraktar R, Knutsen E, Qdaisat A, Chen M, Li Y, Shimizu M, Pang L, Liu K, Liu X, Anfossi S, Zhang H, Koch I, Tran AM, Mohapatra S, Ton A, Kaplan M, Anderson MW, Rothfuss SJ, Silasi R, Keshari RS, Ferracin M, Ivan C, Rodriguez-Aguayo C, Lopez-Berestein G, Georgescu C, Banerjee PP, Basar R, Li Z, Horst D, Vasilescu C, Bertilaccio MTS, Rezvani K, Lupu F, Yeung SC, Calin GA. Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response. J Clin Invest. e-Pub 2023. PMID: 37261908.
      16. Lipe DN, Qdaisat A, Chaftari P, Wattana MK, Krishnamani PP, Reyes-Gibby C, Yeung SJ. Emergency department use by patients who received chimeric antigen receptor T cell infusion therapy. Front Oncol 13:1122329, 2023. e-Pub 2023. PMID: 37007139.
      17. Krishnamani PP, Qdaisat A, Wattana MK, Lipe DN, Sandoval M, Elsayem A, Cruz Carreras MT, Yeung SJ, Chaftari PS. Characteristics and Outcomes of Patients with Cancer Pain Placed in an Emergency Department Observation Unit. Cancers (Basel) 14(23), 2022. e-Pub 2022. PMID: 36497353.
      18. Qdaisat A, Wechsler AH, Cruz Carreras MT, Menendez JR, Lipe D, Highsmith EA, Kamal M, Al-Breiki A, Rojas Hernandez CM, Wu CC, Yeung SJ. Concomitant Deep Vein Thrombosis in Cancer Patients with Unsuspected Pulmonary Embolism. Cancers (Basel) 14(18), 2022. e-Pub 2022. PMID: 36139673.
      19. Lipe DN, Qdaisat A, Rajha E, Al-Breiki A, Cruz Carreras MT, Chaftari P, Yeung SJ, Rice TW. Characteristics and predictors of venous thrombosis recurrence in patients with cancer and catheter-related thrombosis. Res Pract Thromb Haemost 6(6):e12761, 2022. e-Pub 2022. PMID: 36000091.
      20. Kamal M, Baudo M, Joseph J, Geng Y, Qdaisat A. Clinical Outcomes after Immunotherapies in Cancer Setting during COVID-19 Era: A Systematic Review and Meta-Regression. Reports, 2022. e-Pub 2022.
      21. Qdaisat A, Yeung SJ, Rojas Hernandez CH, Samudrala P, Kamal M, Li Z, Wechsler AH. Characteristics and Outcomes of Intracranial Hemorrhage in Cancer Patients Visiting the Emergency Department. J Clin Med 11(3), 2022. e-Pub 2022. PMID: 35160096.
      22. Qdaisat A, Bedrose S, Ezzeldin O, Moawad AW, Yeung SJ, Elsayes KM, Habra MA. The prevalence and spectrum of reported incidental adrenal abnormalities in abdominal computed tomography of cancer patients: The experience of a comprehensive cancer center. Front Endocrinol (Lausanne) 13:1023220, 2022. e-Pub 2022. PMID: 36457558.
      23. Chaftari P, Lipe DN, Wattana MK, Qdaisat A, Krishnamani PP, Thomas J, Elsayem AF, Sandoval M. Outcomes of Patients Placed in an Emergency Department Observation Unit of a Comprehensive Cancer Center. JCO Oncol Pract:OP2100478. e-Pub 2021. PMID: 34905410.
      24. Chaftari P, Qdaisat A, Chaftari AM, Maamari J, Li Z, Lupu F, Raad I, Hachem R, Calin G, Yeung SJ. Prognostic Value of Procalcitonin, C-Reactive Protein, and Lactate Levels in Emergency Evaluation of Cancer Patients with Suspected Infection. Cancers (Basel) 13(16), 2021. e-Pub 2021. PMID: 34439240.
      25. He X, Ji J, Dai X, Qdaisat AZ, Esteva FJ, Hortobagyi GN, Yeung SJ. Association of Cardiovascular Disease Risk Factors with Late Cardiotoxicity and Survival in HER2-positive Breast Cancer Survivors. Clin Cancer Res. e-Pub 2021. PMID: 34117035.
      26. Wu J, Yeung SJ, Liu S, Qdaisat A, Jiang D, Liu W, Cheng Z, Liu W, Wang H, Li L, Zhou Z, Liu R, Yang C, Chen C, Yang R. Cyst(e)ine in nutrition formulation promotes colon cancer growth and chemoresistance by activating mTORC1 and scavenging ROS. Signal Transduct Target Ther 6(1):188, 2021. e-Pub 2021. PMID: 34045438.
      27. Liu W, Qdaisat A, Ferrarotto R, Fuller CD, Guo M, Meyer LA, Narayanan S, Lopez G, Cohen L, Bruera E, Hanna EY, Yeung SJ. Hypomagnesemia and survival in patients with head and neck cancers who received primary concurrent chemoradiation. Cancer 127(4):528-534, 2021. e-Pub 2021. PMID: 33085092.
      28. Liu W, Qdaisat A, Zhou S, Fuller CD, Ferrarotto R, Guo M, Lai SY, Cardoso R, Mohamed ASR, Lopez G, Narayanan S, van Dijk LV, Cohen L, Bruera E, Yeung SJ, Hanna EY. Hypomagnesemia and incidence of osteoradionecrosis in patients with head and neck cancers. Head Neck 43(2):613-621, 2021. e-Pub 2021. PMID: 33094893.
      29. Yeung SJ, Qdaisat A, Chaftari P, Lipe D, Merlin J, Rajha E, Wechsler A, Sandoval M, Viets J, Al-Breiki A, Shah M, Pandey R, Kamal M, Khattab O, Toale K, Wattana M, Elsayem A, Gaeta S, Brock P, Reyes-Gibby C, Alagappan K. Diagnosis and Management of Immune-Related Adverse Effects of Immune Checkpoint Therapy in the Emergency Department. J Am Coll Emerg Physicians Open 1(6):1637-1659, 2020. e-Pub 2020. PMID: 33392573.
      30. Qdaisat A, Wu W, Lin JZ, Al Soud R, Yang Z, Hu Z, Gao S, Wu CC, Liu X, Silvestre J, Hita AG, Viets-Upchurch J, Al Adwan S, Al Haj Qasem N, Cruz Carreras MT, Jacobson KL, Chaftari PS, Abdel-Razeq H, Reyes-Gibby CC, Jim Yeung SC. Clinical and Cancer-Related Predictors for Venous Thromboembolism in Cancer Patients Presenting to the Emergency Department. J Emerg Med 58(6):932-941, 2020. e-Pub 2020. PMID: 32376060.
      31. Qdaisat A, Kamal M, Al-Breiki A, Goswami B, Wu CC, Zhou S, Rice TW, Alagappan K, Yeung SJ. Clinical characteristics, management, and outcome of incidental pulmonary embolism in cancer patients. Blood Adv 4(8):1606-1614, 2020. e-Pub 2020. PMID: 32311012.
      32. Qdaisat A, Yeung SJ, Variyam DE, Badugu P, Ghaly F, Rice TW, Halm JK, Carter BW, Sun J, Gonzalez CE, Viets-Upchurch J, Steele JR, Wu CC. Evaluation of Cancer Patients With Suspected Pulmonary Embolism: Performance of the American College of Physicians Guideline. J Am Coll Radiol 17(1 Pt A):22-30, 2020. e-Pub 2020. PMID: 31376398.
      33. Liu W, Qdaisat A, Lopez G, Narayanan S, Underwood S, Spano M, Reddy A, Guo Y, Yeung SC, Bruera E, Cohen L. Association Between Acupoint Selection, Target Symptoms, and Traditional Chinese Medicine Diagnosis in Real-Time Clinical Practice in a Comprehensive Cancer Center. Integr Cancer Ther 19:1534735420928490, 2020. e-Pub 2020. PMID: 32508209.
      34. Liu W, Qdaisat A, Lee E, Yeung J, Vu K, Lin JZ, Canada T, Zhou S, Cohen L, Bruera E, Yeung SJ. The association between weight stability and parenteral nutrition characteristics and survival in patients with colorectal cancer. Gastroenterol Rep (Oxf) 7(6):419-425, 2019. e-Pub 2019. PMID: 31857903.
      35. Qdaisat A, Wu CC, Yeung SJ. Normal D-dimer levels in cancer patients with radiologic evidence of pulmonary embolism. J Thromb Thrombolysis 48(1):174-179, 2019. e-Pub 2019. PMID: 31041652.
      36. El Majzoub I, Qdaisat A, Chaftari PS, Yeung SJ, Sawaya RD, Jizzini M, Carreras MTC, Abunafeesa H, Elsayem AF. Association of emergency department admission and early inpatient palliative care consultation with hospital mortality in a comprehensive cancer center. Support Care Cancer 27(7):2649-2655, 2019. e-Pub 2019. PMID: 30474736.
      37. Liu W, Qdaisat A, Soliman PT, Ramondetta L, Lopez G, Narayanan S, Zhou S, Cohen L, Bruera E, Yeung SJ. Hypomagnesemia and Survival in Patients with Ovarian Cancer Who Received Chemotherapy with Carboplatin. Oncologist 24(6):e312-e317, 2019. e-Pub 2019. PMID: 30940743.
      38. Qdaisat A, Soud RA, Wu CC, Rojas Hernandez CM, Li J, Meng QH, Abdel-Razeq H, Yeung SJ. Poor performance of D-dimer in excluding venous thromboembolism among patients with lymphoma and leukemia. Haematologica 104(6):e265-e268, 2019. e-Pub 2019. PMID: 30630988.
      39. Liu W, Qdaisat A, Yeung J, Lopez G, Weinberg J, Zhou S, Cohen L, Bruera E, Yeung SJ. The Association Between Common Clinical Characteristics and Postoperative Morbidity and Overall Survival in Patients with Glioblastoma. Oncologist 24(4):529-536, 2019. e-Pub 2019. PMID: 30049883.
      40. Liu W, Qdaisat A, Lopez G, Narayanan S, Underwood S, Spano M, Reddy A, Guo Y, Zhou S, Yeung SC, Bruera E, Garcia MK, Cohen L. Acupuncture for Hot Flashes in Cancer Patients: Clinical Characteristics and Traditional Chinese Medicine Diagnosis as Predictors of Treatment Response. Integr Cancer Ther 18:1534735419848494, 2019. e-Pub 2019. PMID: 31046489.
      41. El Majzoub I, Qdaisat A, Thein KZ, Win MA, Han MM, Jacobson K, Chaftari PS, Prejean M, Reyes-Gibby C, Yeung SJ. Adverse Effects of Immune Checkpoint Therapy in Cancer Patients Visiting the Emergency Department of a Comprehensive Cancer Center. Ann Emerg Med 73(1):79-87, 2019. e-Pub 2019. PMID: 29880440.
      42. Yang Z, Yang R, Kwak MJ, Qdaisat A, Lin J, Begley CE, Reyes-Gibby CC, Yeung SJ. Oncologic emergencies in a cancer center emergency department and in general emergency departments countywide and nationwide. PLoS One 13(2):e0191658, 2018. e-Pub 2018. PMID: 29462166.
      43. Win MA, Thein KZ, Qdaisat A, Yeung SJ. Acute symptomatic hypocalcemia from immune checkpoint therapy-induced hypoparathyroidism. Am J Emerg Med 35(7):1039.e5-1039.e7, 2017. e-Pub 2017. PMID: 28363614.
      44. Lin J, Peng J, Qdaisat A, Li L, Chen G, Lu Z, Wu X, Gao Y, Zeng Z, Ding P, Pan Z. Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer. J Cancer Res Clin Oncol 142(12):2551-2560, 2016. e-Pub 2016. PMID: 27613188.
      45. Lin JZ, Peng JH, Qdaisat A, Lu ZH, Wu XJ, Chen G, Ding PR, Li LR, Gao YH, Zeng ZF, Wan DS, Pan ZZ. Preoperative chemoradiotherapy creates an opportunity to perform sphincter preserving resection for low-lying locally advanced rectal cancer based on an oncologic outcome study. Oncotarget 7(35):57317-57326, 2016. e-Pub 2016. PMID: 27374175.
      46. Yang Z, Qdaisat A, Hu Z, Wagar EA, Reyes-Gibby C, Meng QH, Yeung SC. Cardiac Troponin Is a Predictor of Septic Shock Mortality in Cancer Patients in an Emergency Department: A Retrospective Cohort Study. PLoS One 11(4):e0153492, 2016. e-Pub 2016. PMID: 27077648.
      47. Gao S, Fang L, Phan LM, Qdaisat A, Yeung SC, Lee MH. COP9 signalosome subunit 6 (CSN6) regulates E6AP/UBE3A in cervical cancer. Oncotarget 6(29):28026-41, 2015. e-Pub 2015. PMID: 26318036.
      48. Qdaisat S, Zhao M, Qdaisat A, Harper Allen E, Qdaisat T, Gu J, Hopwood V. Bone Marrow Cultures Stimulated with IL-2/CpG Oligonucleotide Benefits Chromosomal Aberration Detection of CLL Patients when Compared with Standard Culture. J Assoc Genet Technol 40(4):219-22, 2014. e-Pub 2014. PMID: 26030416.

      Review Articles

      1. Bey, T, Qdaisat, AZ. Hyperviscosity Syndrome. Emergency Medicine Clinics of North America 43(3):445-452, 2025. e-Pub 2025. PMID: 40610061.
      2. Wattana, M, Rowland, JW, Qdaisat, AZ, Levavi, H, Anagnostou, T, Sanchez, L, Friedlander, P, Rohs, NC, Lipe, D, Richter, J. Diagnosis and management of bispecific T cell–engaging antibody toxicity. Cancer Treatment Reviews 134, 2025. e-Pub 2025. PMID: 39913958.
      3. Wattana MK, Rowland J, Qdaisat A, Levavi H, Anagnostou T, Sanchez L, Friedlander P, Rohs N, Lipe DN, Richter J. Diagnosis and management of bispecific T cell-engaging antibody toxicity: A primer for emergency physicians. Cancer Treat Rev 134:102889, 2025. e-Pub 2025. PMID: 39913958.
      4. Lipe DN, Qdaisat A, Krishnamani PP, Nguyen TD, Chaftari P, El Messiri N, Srinivasan A, Galvis-Carvajal E, Reyes-Gibby CC, Wattana MK. Myocarditis, Myositis, and Myasthenia Gravis Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A Systematic Review. Diagnostics (Basel) 14(16), 2024. e-Pub 2024. PMID: 39202282.
      5. Zoghbi M, Moussa MJ, Dagher J, Haroun E, Qdaisat A, Singer ED, Karam YE, Yeung SJ, Chaftari P. Brain Metastasis in the Emergency Department: Epidemiology, Presentation, Investigations, and Management. Cancers (Basel) 16(14), 2024. e-Pub 2024. PMID: 39061222.
      6. Singer ED, Faiz SA, Qdaisat A, Abdeldaem K, Dagher J, Chaftari P, Yeung SJ. Hemoptysis in Cancer Patients. Cancers (Basel) 15(19), 2023. e-Pub 2023. PMID: 37835458.
      7. Krishnamani PP, Sandoval M, Chaftari P, Lipe DN, Qdaisat A, Elsayem A, Wattana MK. The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain. Curr Oncol Rep 24(5):595-602, 2022. e-Pub 2022. PMID: 35192121.
      8. Liu W, Lopez G, Narayanan S, Qdaisat A, Geng Y, Zhou S, Spano M, Underwood S, Eclache MG, Dev R, Dalal S, Bruera E, Cohen L. Acupuncture for Cancer-Related Anorexia: a Review of the Current Evidence. Curr Oncol Rep 23(7):82, 2021. e-Pub 2021. PMID: 33948746.

      Abstracts

      1. Liu W, Qdaisat A, Lee E, Yeung J, Borthakur G, Cohen L, Bruera E, Yeung S. Nitrogen energy of parenteral nutrition and survival in patients with leukemia. Clinical nutrition ESPEN 40:P569-570, 2020. e-Pub 2020.
      2. Wechsler A, Qdaisat A, Yeung SC. Survival in Cancer Patients with Intracranial Hemorrhage Presenting to the Emergency Department. The Journal of Emergency Medicine 59(5):P767, 2020. e-Pub 2020.
      3. Qdaisat A, Al-Breiki A, Kamal M, Yeung SC. Characteristics of Unscheduled Emergency Department Revisits in Cancer Patients. The Journal of Emergency Medicine 57(3):P425-426, 2019. e-Pub 2019.
      4. Qdaisat A, Kamal M, Al-Breiki A, Yeung SC. Association of Cancer-Related Factors and Venous Thromboembolism in Patients Presenting to the Emergency Department of a Comprehensive Cancer Center. The Journal of Emergency Medicine 57(3):P425-426, 2019. e-Pub 2019.
      5. Qdaisat A, Wu C, Yeung SJ. Clinical prediction rule for cancer-associated venous thromboembolism in patients presenting to the emergency department. National Comprehensive Cancer Network 23rd Annual Conference, 2018. e-Pub 2018.
      6. Qdaisat A, Wu C, Alsoud S, Yeung SJ. Performance of clinical decision rules in detective venous thromboembolism in cancer patients presented to the emergency department. Oncologic Emergency Medicine Conference, UT MD Anderson Cancer Center, 2018. e-Pub 2018.
      7. Qdaisat A, AlSoud R, Wu C, Abdel-Razeq H, Yeung SJ. Diagnostic accuracy of D-dimer in cancer-associated venous thromboembolism. Oncologic Emergency Medicine Conference, UT MD Anderson Cancer Center, 2018. e-Pub 2018.
      8. Liu W, Qdaisat A, Yeung J, Lopez G, Weinberg JS, Choen L, Bruerar E, S-CJ Y. Association between clinical and biochemical indices and survival in glioblastoma patients. American Society of Clinical Oncology, 2017. e-Pub 2017.
      9. Win MA, Thein KZ, Qdaisat A, Han MM, Yeung SJ. Side efects of immune checkpoint therapy in cancer patients visiting the Emergency Department of a comprehensive cancer center. National Comphrehensive Cancer Network 22nd Annual Conference, 2017. e-Pub 2017.
      10. Yang Z, Yang R, Kwak MJ, Qdaisat A, Lin J, Begley CE, Reyes-Gibby CC, Yeung SC. Oncologic emergencies in a cancer center Emergency Department and in general Emergency Departments countywide and nationwide. Division of Internal Medicine 2017 Research Retreat, The University of Texas MD Anderson Cancer Center, 2017. e-Pub 2017.
      11. Wechsler AH, Qdaisat A, Yeung SC. Incidence and mortality of spontaneous intracranial hemorrhage in oncologic patients presenting to the Emergency Department of a comprehensive cancer center. Division of Internal Medicine 2017 Research Retreat, The University of Texas MD Anderson Cancer Center, 2017. e-Pub 2017.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top